Patents by Inventor Stuart SIEVERS

Stuart SIEVERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
    Publication number: 20250243295
    Abstract: Isolated antigen binding molecules that specifically bind to an anti-CD19 scFv comprising SEQ ID NO: 1 are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Application
    Filed: December 10, 2024
    Publication date: July 31, 2025
    Inventors: Stuart Sievers, Jed Wiltzius
  • Antigen binding molecules specific for an anti-CD19 scFV
    Patent number: 12202909
    Abstract: Isolated antigen binding molecules that specifically bind to an anti-CD19 scFv comprising SEQ ID NO: 1 are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Grant
    Filed: June 9, 2022
    Date of Patent: January 21, 2025
    Assignee: Kite Pharma, Inc.
    Inventors: Stuart Sievers, Jed Wiltzius
  • T cell receptor antigen binding molecules and methods of use thereof
    Patent number: 11820823
    Abstract: Isolated antigen binding molecules that specifically bind to a polypeptide comprising the alpha chain of the constant region of a T cell receptor (TCR) are provided. The antigen binding molecules may be used in the methods provided herein.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: November 21, 2023
    Assignee: Kite Pharma, Inc.
    Inventors: Stephanie Astrow, Stuart Sievers, Jed Wiltzius
  • Antigen binding molecules and methods of use thereof
    Patent number: 11608517
    Abstract: Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GSTSGSGKPGSGEGSTKG (SEQ ID NO: 1), GSGKPGSGEG (SEQ ID NO: 2), GKPGSGEG (SEQ ID NO: 3), SGKPGSGE (SEQ ID NO: 499) and KPGSG (SEQ ID NO: 500) are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: March 21, 2023
    Assignee: Kite Pharma, Inc.
    Inventors: Jed Wiltzius, Stuart Sievers, Arianne Perez Garcia
  • ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
    Publication number: 20220403050
    Abstract: Isolated antigen binding molecules that specifically bind to an anti-CD19 scFv comprising SEQ ID NO: 1 are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Application
    Filed: June 9, 2022
    Publication date: December 22, 2022
    Inventors: Stuart Sievers, Jed Wiltzius
  • ANTI-IDIOTYPIC ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
    Publication number: 20220396628
    Abstract: Isolated antigen binding molecules that specifically bind to a CLL-1 binding molecule are provided. The antigen binding molecules may be used in the methods provided herein.
    Type: Application
    Filed: October 23, 2020
    Publication date: December 15, 2022
    Inventors: Stuart Sievers, Jed J.W. Wiltzius
  • Antigen binding molecules specific for an anti-CD19 scFv
    Patent number: 11384155
    Abstract: Isolated antigen binding molecules that specifically bind to an anti-CD19 scFv comprising SEQ ID NO: 1 are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: July 12, 2022
    Assignee: Kite Pharma, Inc.
    Inventors: Jed Wiltzius, Stuart Sievers
  • ANTI-IDIOTYPIC ANTIBODIES DIRECTED TO THE ANTIGEN-BINDING PORTION OF AN BCMA-BINDING MOLECULE
    Publication number: 20200377609
    Abstract: Isolated antigen binding molecules that specifically bind to a BCMA binding molecule are provided. The antigen binding molecules may be used in the methods provided herein. Specifically, monoclonal anti-idiotypic antibodies are provided which bind to the antigen-binding portion of a BCMA-binding molecule, in particular of anti-BCMA CARs.
    Type: Application
    Filed: February 14, 2019
    Publication date: December 3, 2020
    Inventors: Stuart Sievers, Jed J.W. Witzius
  • ANTIGEN BINDING MOLECULES SPECIFIC FOR AN ANTI-CD19 SCFV
    Publication number: 20200354475
    Abstract: Isolated antigen binding molecules that specifically bind to an anti-CD19 scFv comprising SEQ ID NO: 1 are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Application
    Filed: March 10, 2020
    Publication date: November 12, 2020
    Inventors: Jed Wiltzius, Stuart Sievers
  • T CELL RECEPTOR ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
    Publication number: 20200308281
    Abstract: Isolated antigen binding molecules that specifically bind to a polypeptide comprising the alpha chain of the constant region of a T cell receptor (TCR) are provided. The antigen binding molecules may be used in the methods provided herein.
    Type: Application
    Filed: October 26, 2018
    Publication date: October 1, 2020
    Inventors: Stephanie Astrow, Stuart Sievers, Jed Wiltzius
  • Antigen binding molecules specific for an anti-CD19 scFv
    Patent number: 10626187
    Abstract: Isolated antigen binding molecules that specifically bind to an anti-CD19 scFv comprising SEQ ID NO: 1 are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: April 21, 2020
    Assignee: Kite Pharma, Inc.
    Inventors: Jed Wiltzius, Stuart Sievers
  • ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
    Publication number: 20200048681
    Abstract: Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GSTSGSGKPGSGEGSTKG (SEQ ID NO: 1), GSGKPGSGEG (SEQ ID NO: 2), GKPGSGEG (SEQ ID NO: 3), SGKPGSGE (SEQ ID NO: 499) and KPGSG (SEQ ID NO: 500) are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Application
    Filed: October 29, 2019
    Publication date: February 13, 2020
    Inventors: Jed Wiltzius, Stuart Sievers, Arianne Perez Garcia
  • Antigen binding molecules and methods of use thereof
    Patent number: 10501775
    Abstract: Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GSTSGSGKPGSGEGSTKG (SEQ ID NO: 1), GSGKPGSGEG (SEQ ID NO: 2), GKPGSGEG (SEQ ID NO: 3), SGKPGSGE (SEQ ID NO: 499) and KPGSG (SEQ ID NO: 500) are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: December 10, 2019
    Assignee: Kite Pharma, Inc.
    Inventors: Jed Wiltzius, Stuart Sievers, Arianne Perez Garcia
  • ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
    Publication number: 20180086846
    Abstract: Isolated antigen binding molecules that specifically bind to an anti-CD19 scFv comprising SEQ ID NO: 1 are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Application
    Filed: September 27, 2017
    Publication date: March 29, 2018
    Inventors: Jed WILTZIUS, Stuart SIEVERS
  • ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
    Publication number: 20180016620
    Abstract: Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GSTSGSGKPGSGEGSTKG (SEQ ID NO: 1), GSGKPGSGEG (SEQ ID NO: 2), GKPGSGEG (SEQ ID NO: 3), SGKPGSGE (SEQ ID NO: 499) and KPGSG (SEQ ID NO: 500) are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Application
    Filed: July 11, 2017
    Publication date: January 18, 2018
    Inventors: Jed WILTZIUS, Stuart SIEVERS, Arianne PEREZ GARCIA